JACC: Case Reports (May 2024)

Transcaval Transcatheter Aortic Valve Replacement for Pure Aortic Regurgitation Using a Dedicated Self-Expanding Device

  • Jonathan Curio, MD,
  • Stephan Nienaber, MD,
  • Elmar W. Kuhn, MD,
  • Kaveh Eghbalzadeh, MD,
  • Wael Ahmad, MD,
  • Arash Mehdiani, MD,
  • Jörg Schröder, MD,
  • Maria Isabel Körber, MD,
  • Hendrik Wienemann, MD,
  • Stephan Baldus, MD,
  • Matti Adam, MD

Journal volume & issue
Vol. 29, no. 10
p. 102320

Abstract

Read online

Novel dedicated devices allow transcatheter treatment of pure aortic regurgitation (AR). The JenaValve Trilogy Heart Valve System was introduced as the first dedicated and on-label AR transcatheter aortic valve replacement system, implementing a locator-based and calcium-independent anchoring mechanism. Here, we present the first-in-human transcatheter aortic valve replacement for pure AR via a transcaval access in a patient with prohibitive alternative arterial accesses.

Keywords